Literature DB >> 34508230

CV benefits of finerenone in T2DM and CKD.

Karina Huynh1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34508230     DOI: 10.1038/s41569-021-00621-5

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.

Authors:  Bertram Pitt; Gerasimos Filippatos; Rajiv Agarwal; Stefan D Anker; George L Bakris; Peter Rossing; Amer Joseph; Peter Kolkhof; Christina Nowack; Patrick Schloemer; Luis M Ruilope
Journal:  N Engl J Med       Date:  2021-08-28       Impact factor: 91.245

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.